168 related articles for article (PubMed ID: 29652549)
1. Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length.
Li AM; Thyagu S; Maze D; Schreiber R; Sirrs S; Stockler-Ipsiroglu S; Sutherland H; Vercauteren S; Schultz KR
Pediatr Hematol Oncol; 2018 Feb; 35(1):45-51. PubMed ID: 29652549
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
4. A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): a case report.
Schroeder T; Hildebrandt B; Mayatepek E; Germing U; Haas R
J Med Case Rep; 2008 Sep; 2():319. PubMed ID: 18826620
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b.
Calderwood S; Kilpatrick L; Douglas SD; Freedman M; Smith-Whitley K; Rolland M; Kurtzberg J
Blood; 2001 Jan; 97(2):376-82. PubMed ID: 11154211
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.
Freedman MH; Bonilla MA; Fier C; Bolyard AA; Scarlata D; Boxer LA; Brown S; Cham B; Kannourakis G; Kinsey SE; Mori PG; Cottle T; Welte K; Dale DC
Blood; 2000 Jul; 96(2):429-36. PubMed ID: 10887102
[TBL] [Abstract][Full Text] [Related]
7. Acute myelogenous leukemia and glycogen storage disease 1b.
Pinsk M; Burzynski J; Yhap M; Fraser RB; Cummings B; Ste-Marie M
J Pediatr Hematol Oncol; 2002 Dec; 24(9):756-8. PubMed ID: 12468919
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1.
Visser G; Rake JP; Labrune P; Leonard JV; Moses S; Ullrich K; Wendel U; Groenier KH; Smit GP
Eur J Pediatr; 2002 Oct; 161 Suppl 1():S83-7. PubMed ID: 12373578
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1b.
Lesma E; Riva E; Giovannini M; Di Giulio AM; Gorio A
Int J Immunopathol Pharmacol; 2005; 18(2):297-307. PubMed ID: 15888252
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory bowel disease-like colitis in glycogen storage disease type 1b.
Yamaguchi T; Ihara K; Matsumoto T; Tsutsumi Y; Nomura A; Ohga S; Hara T
Inflamm Bowel Dis; 2001 May; 7(2):128-32. PubMed ID: 11383585
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the diagnosis, treatment, and follow-up of a group of Turkish pediatric glycogen storage disease type 1b patients with varying clinical presentations and a novel mutation.
Küçükçongar Yavaş A; Engin Erdal A; Bilginer Gürbüz B; Ünlüsoy Aksu A; Kasapkara ÇS
J Pediatr Endocrinol Metab; 2023 Nov; 36(11):1092-1099. PubMed ID: 37791580
[TBL] [Abstract][Full Text] [Related]
12. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.
Freedman MH; Alter BP
Semin Hematol; 2002 Apr; 39(2):128-33. PubMed ID: 11957196
[TBL] [Abstract][Full Text] [Related]
13. Detection of myelodysplastic syndrome/ acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF.
Imashuku S; Hibi S; Bessho F; Tsuchida M; Nakahata T; Miyazaki S; Tsukimoto I; Hamajima N;
Haematologica; 2003 Nov; 88(11):ECR31. PubMed ID: 14607763
[TBL] [Abstract][Full Text] [Related]
14. Glycogen storage disease.
Kannourakis G
Semin Hematol; 2002 Apr; 39(2):103-6. PubMed ID: 11957192
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia.
Lehrnbecher T; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Creutzig U
Blood; 2007 Feb; 109(3):936-43. PubMed ID: 17008536
[TBL] [Abstract][Full Text] [Related]
16. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
[TBL] [Abstract][Full Text] [Related]
17. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.
Estey E; Thall P; Andreeff M; Beran M; Kantarjian H; O'Brien S; Escudier S; Robertson LE; Koller C; Kornblau S
J Clin Oncol; 1994 Apr; 12(4):671-8. PubMed ID: 7512125
[TBL] [Abstract][Full Text] [Related]
18. Malignant myeloid transformation in congenital forms of neutropenia.
Freedman MH; Alter BP
Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
Dong F; Brynes RK; Tidow N; Welte K; Löwenberg B; Touw IP
N Engl J Med; 1995 Aug; 333(8):487-93. PubMed ID: 7542747
[TBL] [Abstract][Full Text] [Related]
20. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.
Rosenberg PS; Alter BP; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Fier C; Freedman M; Kannourakis G; Kinsey S; Schwinzer B; Zeidler C; Welte K; Dale DC;
Blood; 2006 Jun; 107(12):4628-35. PubMed ID: 16497969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
